Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C000654629
http://purl.bioontology.org/ontology/MESH/C000654629
|
|---|---|
| Preferred Name | H3B-6545 |
| Synonyms |
((2E)-N,N-dimethyl-4-((2-((5-((1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenylbut-1-en-1-yl)pyridin-2-yl)oxy)ethyl)amino)but-2-enamide) hydrochloride salt
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | ((2E)-N,N-dimethyl-4-((2-((5-((1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenylbut-1-en-1-yl)pyridin-2-yl)oxy)ethyl)amino)but-2-enamide) hydrochloride salt
|
|---|---|
| prefLabel | H3B-6545
|
| Scope Statement | selective estrogen receptor (ER)alpha covalent antagonist
|
| type | |
| tui |
T109
T121
|
| HM |
D011725
D007191
|
| SC | 1
|
| TERMUI |
T000995889
T000995890
|
| TH | NLM (2019)
|
| SRC | Cancer Chemother Pharmacol. 2019 Jan;83(1):151-160.
|
| MMR | 20191112
|
| notation | C000654629
|
| Semantic type UMLS property | |
| cui |
C4684940
C5227778
|
| MeSH Frequency | 4
|
| DSC | 20191112
|
| Inverse of RB | 0
|
| Mapped to | |
| MDA | 20191112
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |